Michael Dodds

Executive Director at Certara; Vice President, Quantitative Sciences at Lumen Bioscience

Role
Executive Director, Consulting Services at Certara
Location
Seattle, WA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Michael Dodds

Mike’s research focuses on the application of pharmacometrics: mathematical models of biology,(patho)-physiology, pharmacology and disease that quantify beneficial and undesirable interactions between drugs and patients to predict outcome [Barrett 2008]. Importantly, accurate and precise quantitative prediction of patient outcome allows for informed drug-development decisions. The following sections detail examples where Mike has applied pharmacometric research principals to aid in drug-development, with an emphasis on decision quality and business impact.Tools-of-the-trade:Population approach: NONMEM 7.2, PDx-Pop, Xpose, SPKGeneral purpose and custom programming: MATLAB, C++, SAS, S-Plus/RModel development: Berkeley Madonna, SAAM II, WinPOPTNoncompartmental analysis: WinNonlin (LIMS and database integration)Google Scholar Publication Tracker: https://scholar.google.com/citations?hl=en & & view_op=list_works & sortby=pubdateORCID Id:

Experience

  1. Executive Director, Consulting Services

    Certara

    Oct 2015 — Present · Seattle, WA, US

    Mike Dodds has been working in the pharmacometrics field since 2005. He joined Certara (formerly Quantitative Solutions) in 2015 in the role of Director Consulting Services and is based in Seattle, Washington. Previously, he worked for ZymoGenetics in the Department of Pharmacokinetics and Pharmacodynamics, providing predictive modeling support for emerging drug candidates in the areas of autoimmunity, coagulation and oncology. Prior to that, he worked for Amgen in the Department of Pharmacokinetics and Drug Metabolism and then Clinical Pharmacology Modeling and Simulation as a pharmacometrics subject matter expert, providing modeling and simulation expertise to guide development program decisions around target selection, candidate selection, preclinical-to-clinical translation, Phase 1, 2 and 3 dose and regimen selection, and biosimilar development.

Education

  • University of Washington

    Ph.D., Bioengineering

    2000 — 2004

  • North Carolina State University

    B.S., Biochemistry

    1991 — 1995

  • North Carolina School of Science and Mathematics

    G.E.D.

    1989 — 1991

  • North Carolina State University

    B.S., Chemical Engineering

    1991 — 1995

  • Montana State University-Bozeman

    M.S., Chemical Engineering

    1996 — 1998

Skills

  • R
  • Sas
  • Drug Development
  • Pharmacology
  • Biotechnology
  • C++
  • Pk/Pd
  • Modeling
  • Clinical Development
  • Clinical Trials
  • Drug Discovery
  • Programming
  • Drug Metabolism
  • Pharmaceutical Industry
  • Fortran
  • Life Sciences
  • Oncology
  • Pharmacokinetics
  • Pharmacodynamics
  • Matlab
  • Data Analysis
  • Ind

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Michael Dodds — Executive Director, Consulting Services at Certara in Seattle, WA, US | Unifers